Based on 1 analyst offering 12 month price targets for Biovie Inc
Min Forecast
$30.00+867.74%
Avg Forecast
$30.00+867.74%
Max Forecast
$30.00+867.74%
Should I buy or sell BIVI stock?
Based on 1 analyst offering ratings for Biovie Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although BIVI's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates BIVI as a "Sell". Stocks with a Zen Rating of Sell have trailed the market by -4.50%. Learn More
Be the first to know when Wall Street analysts revise their BIVI stock forecasts and price targets.
BIVI stock forecasts by analyst
Analyst / Firm
Rating
Action
Price Target
Upside/Downside
Date
Analyst Color
locked
locked
$00.00
+00.00%
2024-07-01
1 of 1
Forecast return on equity
Is BIVI forecast to generate an efficient return?
Company
N/A
Industry
137.48%
Market
70.82%
Forecast return on assets
Is BIVI forecast to generate an efficient return on assets?
Is Biovie Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: BIVI) stock is to Strong Buy BIVI stock.
Out of 1 analyst, 1 (100%) are recommending BIVI as a Strong Buy, 0 (0%) are recommending BIVI as a Buy, 0 (0%) are recommending BIVI as a Hold, 0 (0%) are recommending BIVI as a Sell, and 0 (0%) are recommending BIVI as a Strong Sell.
What is BIVI's forecast return on equity (ROE) for 2025-2027?
(NASDAQ: BIVI) forecast ROE is N/A, which is considered weak.
What is BIVI's Price Target?
According to 1 Wall Street analyst that have issued a 1 year BIVI price target, the average BIVI price target is $30.00, with the highest BIVI stock price forecast at $30.00 and the lowest BIVI stock price forecast at $30.00.
The Wall Street analyst predicted that Biovie's share price could reach $30.00 by Jul 1, 2025. The average Biovie stock price prediction forecasts a potential upside of 867.74% from the current BIVI share price of $3.10.
What is BIVI's forecast return on assets (ROA) for 2025-2027?
(NASDAQ: BIVI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 22.54%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.